Heart Failure: Therapeutic Updates

Therapeutic updates in heart failure management have revolutionized patient care. Novel treatments, such as angiotensin receptor-neprilysin inhibitors (ARNIs), sodium-glucose co-transporter-2 inhibitors (SGLT2 inhibitors), and cardiac resynchronization therapy (CRT), have shown remarkable benefits in reducing hospitalizations, improving symptoms, and prolonging survival. Continuous research aims to optimize therapeutic options and enhance outcomes for heart failure patients.

    Related Conference of Heart Failure: Therapeutic Updates

    October 20-21, 2026

    15th World Heart Congress

    London, UK
    November 09-10, 2026

    7th Annual Summit on Cardiology and Heart Diseases

    Paris, France
    November 16-17, 2026

    8th World Heart Congress

    Tokyo, Japan
    November 23-24, 2026

    40th World Congress on Heart Diseases

    Toronto, Canada
    November 25-26, 2026

    33rd World Heartcare Summit

    Paris, France
    January 26-27, 2027

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2027

    16th World Heart Congress

    Paris, France
    May 13-14, 2027

    10th Annual Heart Rhythm Conference

    Rome, Italy
    June 17-18, 2027

    10th World Heart and Brain Conference

    London, UK
    June 21-22, 2027

    8th European Summit on Cardiology Research

    Zurich, Switzerland

    Heart Failure: Therapeutic Updates Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in